Who invested in APT Pharmaceuticals?
APT Pharmaceuticals's investors include Versant Ventures, Vivo Ventures, Charter Life Sciences, Great Point Partners and InterWest Partners, and 2 more on record.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$54Mraised across 2 rounds since 2007, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by aptbio.com
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
APT Pharmaceuticals's investors include Versant Ventures, Vivo Ventures, Charter Life Sciences, Great Point Partners and InterWest Partners, and 2 more on record.
APT Pharmaceuticals has raised $54M across 2 rounds since 2007.
APT Pharmaceuticals's most recent round was a Series A of $32M in Sept 2008.
Its most recent round, $32M in Sept 2008, is also its largest on record.
APT Pharmaceuticals's first round on record, in Oct 2007, was backed by Versant Ventures, Vivo Ventures and Charter Life Sciences and 1 others.
APT Pharmaceuticals's latest named round is a Series A, in Sept 2008.
APT Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.